Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:23 July,2020

Delhi : Screening begins for vaccine volunteers

New Delhi: Health screening of people who volunteered for the trial of Covaxin — India’s indigenous vaccine for Covid-19 — has started.
Delhi-based Dr Dangs Lab, which has been selected as the central lab for human clinical trials of Covaxin, said it has already started receiving samples from 50 to 100 subjects per day from various trial sites for safety testing. ,“We will be increasing operations as per assigned timelines to cover 12 sites across the country over this month,” Dr Navin Dang, founder of Dr Dangs Lab, said. ,Covaxin has been developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research. It is currently undergoing phase I trial, during which 375 people will be vaccinated to assess safety of the vaccine and to calculate the dose range. ....read more

Need for Uniform COVID Policies

Access to healthcare services is the right of every person not only in the non-COVID era but also during the COVID pandemic.

Join us today at 7:00 pm as we discuss the “Need for Uniform COVID Policies” in Medtalks with Dr KK Aggarwal COVID edition
Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php

CMAAO Coronavirus Facts and Myth Buster: COVID Update

With inputs from Dr Monica Vasudev
994: When the prevalence of COVID-19 is high, even atypical imaging features are more likely to be COVID-19.
995: Typical chest CT findings in COVID-19 pneumonia include bilateral, peripheral and basal-predominant ground-glass opacities (GGOs) and/or consolidation, followed later by a mixed pattern of crazy paving, architectural distortion and perilobular abnormalities superimposed on GGOs that slowly resolve.
996: Upper lobe or peribronchovascular distribution of GGOs, cavitation, lymphadenopathy, and pleural thickening are found atypically. ....read more

World COVID Meter 22nd July: India Number 3, 213 Countries Affected

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17 ,Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity ,Doubling time India 21 days, USA 33 days, Brazil 13 days, Russia 18 days, Spain 47 days, UK 35 days, Italy 55 days, France 49 days, Turkey 37 days ,Coronavirus Cases: 15,091,880,Deaths: 619,410,Recovered: 9,110,208,ACTIVE CASES: 5,362,262 ....read more

An empty mind is the devils house

It is an old saying that "Khali dimag shaitan ka ghar". ,Empty mind means when you are doing nothing and Shaitan means negative thoughts. In terms of Vedic science, negative thoughts mean absence of positive thoughts and they are often equated to darkness, which is absence of light. ,Positive thoughts always need efforts and exertions, while negative thoughts are spontaneous and without exertion. It is recommended that one should think differently and positive otherwise there will be spontaneous appearance of negative thoughts. ....read more

Video of The day

My COVID 19 rights



Healthcare News Monitor
How digital technologies can help drug makers to fight against Coronavirus?

When every country is fighting in their own way to stop the spread of coronavirus across the world. The pharmaceutical industries and medical institutes played a vital part to fight against Covid-19, supplying life-saving drugs that help the patient to recover. Alongside this, they are working on new treatments that can completely cure the patients fighting the coronavirus. However, the pandemic imposed some severe challenges for drugmakers like disruptions in the supply chain. This actually exposed the sector’s vulnerability and their need for greater resilience.

Glenmark Pharma rises after Favipiravir shows encouraging results in Phase 3 trial
Business Standard

Glenmark Pharmaceuticals rose 3.17% to Rs 426.80 after the company announced top-line results from phase 3 clinical trial of favipiravir in patients with mild to moderate COVID-19.
The drug maker on Wednesday announced top-line results from a Phase 3 clinical trial in mild to moderate COVID-19 patients conducted across seven clinical sites in India. The open-label randomized, multicenter clinical trial, conducted in 150 patients, evaluated the efficacy and safety of Favipiravir plus standard supportive care (Favipiravir treatment arm) in mild to moderate patients, randomized within a 48 hour window of testing RT-PCR positive for COVID-19.

In India, recovered Covid-19 patients are returning to hospitals with heart problems or lung damage

It is quite clear now that the impact of Covid-19 lies way beyond influenza-like conditions, even for the majority who are not much affected by this dreaded disease. It is also evident that this disease affects many more organs beyond the lungs and the respiratory tract including the heart, kidney, brain, and the gastrointestinal tract. What more do we know and how can we be alert about these conditions, particularly since some of that impact can be long-term? ,We speak with S Chatterjee, senior consultant, internal medicine, Apollo Hospital, New Delhi, and Jeenam Shah, consultant chest physician and interventional pulmonologist at Saifee, Wockhardt and Bhatia Hospitals in Mumbai.

Chhattisgarh: Woman carried in cooking vessel across river to hospital
The Indian Express

A pregnant and close-to-term woman was carried in a cooking vessel across a river to reach the nearest hospital, nearly 15 km away, in Chhattisgarh’s Bijapur district and gave birth to a still-born baby, allegedly due to negligence of the staff at the community hospital in Bhopalpatnam town, according to her husband. ,Her husband – Harish Yalam – complained the stillbirth was the result of hospital staff waiting for the duty doctor to arrive for hours to look at his wife – Lakshmi Yalam. The incident took place on July 13. ,Harish said he has lodged a complaint with the block medical officer (BMO) and will meet the collector if no action is taken. ,BMO Ajay Ramteke told the media that showcause notices have been served on three hospital staff. “We have received the complaint and are investigating what happened that night. Due action will be taken,” he said.